Search results
Results From The WOW.Com Content Network
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4][5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...
Trametinib. Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma [4][5] and glioma. [6][7] It is a MEK inhibitor drug with anti-cancer activity. [8] It inhibits MEK1 and MEK2. [8]
Ribociclib is a kinase inhibitor. [4] It was developed by Novartis and Astex Pharmaceuticals. [6] The most common side effects include infections, low levels of white blood cells, headache, cough, nausea (feeling sick), vomiting, diarrhea, constipation, tiredness, hair loss and rash. [5]
Call live aol support at. 1-800-358-4860. Get live expert help with your AOL needs—from email and passwords, technical questions, mobile email and more. Identify legitimate AOL websites, requests, and communications. Scammers and bad actors are always looking for ways to get personal info with malicious intent.
Ofatumumab is a fully human anti- CD20 monoclonal antibody whose epitope is distinct from that of rituximab. [24] Ofatumumab binds to a distinct epitope on small and large extracellular loops of CD20. [25][26] The CD20 antigen is expressed on solely B cell lymphocytes. [24] Compared with rituximab, ofatumumab binds more tightly to CD20 with a ...
Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. [3][4] Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis. [5] It is a thrombopoietin receptor agonist. [3]
vaccines, blood testing. Revenue. $1.921 billion (2005) Number of employees. 5,400 (2005) Website. www.chiron.com. Chiron Corporation (/ ˈkaɪrɒn / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006.